ivan Limachi

Dr. ivan Limachi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
DADiandra Arévalo-Lopéz
Diandra Arévalo-Lopéz
NNNélida Nina
Nélida Nina
JTJuan C. Ticona
Juan C. Ticona
ILivan Limachi
ivan Limachi
ESEfrain Salamanca
Efrain Salamanca
AGAlberto Giménez
Alberto Giménez

15 February 2021 in Molecules
Verified
Journal Article
Open access
PDF file
ILivan Limachi
ivan Limachi
MRMariela Gonzalez Ramirez
Mariela Gonzalez Ramirez
SMSophie Manner
Sophie Manner
JTJuan C. Ticona
Juan C. Ticona
ESEfrain Salamanca
Efrain Salamanca
OSOlov Sterner
Olov Sterner
The fractionation of an ethanol extract of the bark of Trichilia adolfi yielded four novel limonoids (trichilinones A-D, 1–4), with five fused rings and related to the hortiolide-type limonoids. Starting with an ε-lactone, which is α,β-unsaturated in trichilinones A and D (1 and 4), attached to a tetrahydrofuran ring that is connected to an unusual bicyclo [5.1.0] hexane system, joined with a cyclopentanone with a 3-furanyl substituent [(2-oxo)-furan-(5H)-3-yl in trichilinone D (4)], the four compounds isolated display a new 7/5/3/5/5 limonoid ring system. Their structures were established based on extensive analysis of NMR spectroscopic data. As the crude extract possessed anti-leishmanial properties, the compounds were assayed for cytotoxic and anti-parasitic activities in vitro in murine macrophages cells (Raw 264.7) and leishmania promastigotes (L. amazoniensis and L. braziliensis), respectively. The compounds showed moderate cytotoxicity (approximately 70 μg/mL), but are not responsible for the leishmanicidal effect of the extract.

21 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MRMariela Gonzalez Ramirez
Mariela Gonzalez Ramirez
ILivan Limachi
ivan Limachi
SMSophie Manner
Sophie Manner
JTJuan C. Ticona
Juan C. Ticona
ESEfrain Salamanca
Efrain Salamanca
OSOlov Sterner
Olov Sterner
In addition to the trichilianones A–D recently reported from Trichilia adolfi, a continuing investigation of the chemical constituents of the ethanol extract of the bark of this medicinal plant yielded the five new limonoids 1–5. They are characterized by having four fused rings and are new examples of prieurianin-type limonoids, having a ε-lactone which in 4 and 5 is α, β- unsaturated. The structures of the isolated metabolites were determined by high field NMR spectroscopy and HR mass spectrometry. The new metabolites were shown to have the ε-lactone fused with a tetrahydrofuran ring which is connected to an oxidized hexane ring joined with a cyclo-pentanone having a 3-furanyl substituent. As the crude extract possesses antileishmanial activity, the compounds were assayed for cytotoxic and antiparasitic activities in vitro in murine macrophage cells (raw 264.7 cells) and in Leishmania amazoniensis as well as L. braziliensis promastigotes. Metabolites 1–3 and 5 showed moderate cytotoxicity (between 30–94 µg/mL) but are not responsible for the antileishmanial effect of the extract.

13 August 2026 in Molecules
Verified
Journal Article
Open access
PDF file
Sergio Fallone AndradeSergio Fallone Andrade
Sergio Fallone Andrade
Eduardo BreviglieriEduardo Breviglieri
Eduardo Breviglieri
ILivan Limachi
ivan Limachi
LSLuísa Mota gastric ulcer Luisa Mota Da Silva
Luísa Mota gastric ulcer Luisa Mota Da Silva
TBThaise Boeing
Thaise Boeing
VFValdir Cechinel Filho
Valdir Cechinel Filho
The treatment of gastric ulcers based on antisecretory drugs is often associated with side effects and high recurrence rates, reinforcing the need for new therapeutic alternatives. Medicinal chemistry guided by natural prototypes represents a productive strategy in this context. The antiulcer potential of 2-phenylquinoline (2-PQ), an alkaloid from Conchocarpus longifolius (A.St.-Hil.) Kallunki & Pirani (syn. Galipea longiflora Krause), has been previously reported by our research group. In the present work, four 2-PQ derivatives were synthesized—2,4-diphenylquinoline (1), 2-(4-methoxyphenyl) quinoline (2), 2-phenylquinolin-4-ol (3), and 4-methoxy-2-phenylquinoline (4)—and evaluated for gastroprotective activity in the HCl/ethanol-induced gastric ulcer model in mice. The quinoline derivatives were prepared mainly by trifluoroacetic acid-catalyzed condensations of aminated benzaldehyde or benzophenone precursors with the corresponding ketones under reflux at 100 °C, affording yields of 68–94%. Compound 3 was synthesized via a two-step sequence involving the acylation of 2-aminobenzophenone followed by base-induced cyclization, providing an 85% yield. Compound 4 was obtained by O-methylation of compound 3 using iodomethane (MeI) and potassium carbonate (K2CO3) in dimethylformamide (DMF), affording a 95% yield. So, this study provides the first comparative analysis linking structural modifications to gastroprotective activity in synthetic quinoline derivatives inspired by 2-phenylquinoline, a natural alkaloid previously shown to exert gastroprotective effects. Carbenoxolone (200 mg/kg, p.o., positive control) inhibited gastric lesion formation by 94.1%. The synthetic quinoline derivatives also showed significant gastroprotective activity after oral administration (30 mg/kg), reducing ulcer area by 72.4% (compound 1), 76.1% (compound 2), 49.1% (compound 3), and 66.1% (compound 4). Compounds 2, 3, and 4 further retained efficacy following intraperitoneal administration (3 mg/kg), whereas compound 1 was inactivated by this route. Overall, compound 4 exhibited the greatest efficacy, significantly reducing the gastric lesion area, decreasing lipid hydroperoxide (LOOH) and tumor necrosis factor-alpha (TNF-α) levels, and increasing glutathione (GSH) content in ulcerated gastric tissue. These findings suggest that its gastroprotective effects are mediated by antioxidant and anti-inflammatory mechanisms, identifying compound 4 as the most promising candidate for the prevention and treatment of peptic ulcers. Its promising pharmacological profile warrants further investigation to elucidate its molecular mechanisms of action, assess its safety and efficacy in additional preclinical studies, and explore its potential for future therapeutic development.

21 May 2026 in Acta Biológica Colombiana
Verified
Journal Article
Open access
PDF file
Ariel Angel Cespedes-LlaveAriel Angel Cespedes-Llave
Ariel Angel Cespedes-Llave
MCMaría Luisa De la Cruz-Claure
María Luisa De la Cruz-Claure
MLMaría Cristina López-Roberts
María Cristina López-Roberts
RLRoxana Lovera-Cruz
Roxana Lovera-Cruz
AGAlberto José Giménez-Turba
Alberto José Giménez-Turba
NNNélida Nina
Nélida Nina
The study provides information on the bioactive properties of honey and propolis from eight species of stingless bees from the “Tua Ta Uypi” Meliponary (Cochabamba, Bolivia). The quality of honey from seven stingless bee species and Apis mellifera was evaluated, along with its antimicrobial activity using the agar diffusion method against ATCC strains (25922 Escherichia coli and 25923 Staphylococcus aureus). Additionally, metabolites were extracted from the propolis of five species through ethanol maceration and preliminarily identified using thin-layer chromatography. Finally, propolis extracts from four species were, in vitro, tested against strains of Leishmania amazonensis, L. braziliensis and Giardia lamblia. The results reveal variations in honey quality among species, with the antimicrobial activity of Scaptotrigona depilis, Melipona rufiventris, and Tetragona goettei honey showing inhibition zones greater than 17 mm for E. coli and 16 mm for S. aureus, like the positive controls (Amikacin and Erythromycin). In the propolis of Melipona eburnea and Tetragonisca angustula, were observed compounds consistent with terpenes and poliphenols. In the antiparasitic tests, T. angustula propolis showed activity against both Leishmania strains and Giardia, while the propolis from S. polysticta and S. yungasensis exhibited activity against G. lamblia. These findings highlight the therapeutic potential of the products from these stingless bees.